Literature DB >> 11962255

Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities.

L Di Marzio1, F P Russo, S D'Alò, L Biordi, S Ulisse, G Amicosante, C De Simone, M G Cifone.   

Abstract

The aim of the present work was, first, to analyze the apoptotic effect in vitro of sonicated preparations of selected strains of lactic acid bacteria on normal and tumor human lymphocytes. Incubation with bacterial samples led to a relevant time-dependent apoptotic cell death of Jurkat cells but not normal human peripheral blood lymphocytes. Lactobacillus brevis (CD2) samples were more efficient in inducing apoptosis of Jurkat cells than were samples of Streptococcus thermophilus (S244). In an attempt to characterize the mechanisms underlying these effects, we found that the apoptotic death-inducing ability of S244 preparations could be attributed to the ability of high levels of neutral sphingomyelinase activity to generate relevant amounts of ceramide, a known apoptotic death messenger, in Jurkat cells. On the other hand, our results indicate that apoptosis induced by CD2 samples could also be associated with high levels of arginine deiminase activity, which in turn was able to downregulate polyamine synthesis in Jurkat cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11962255     DOI: 10.1207/S15327914NC402_16

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  8 in total

Review 1.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

2.  Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.

Authors:  T Maekawa; G Hajishengallis
Journal:  J Periodontal Res       Date:  2014-02-01       Impact factor: 4.419

3.  VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

Authors:  I Soo; K L Madsen; Q Tejpar; B C Sydora; R Sherbaniuk; B Cinque; L Di Marzio; M Grazia Cifone; C Desimone; R N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

Review 4.  Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism.

Authors:  Francesco Russo; Michele Linsalata; Antonella Orlando
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

5.  Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase.

Authors:  Sandra Angulo; Albert Morales; Silvio Danese; Laura Llacuna; Maria Carme Masamunt; Nicole Pultz; Maria Grazia Cifone; Claudio De Simone; Salvadora Delgado; Jordi Vila; Julián Panés; Curtis Donskey; Jose C Fernández-Checa; Claudio Fiocchi; Miquel Sans
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

6.  Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation.

Authors:  Atul Sharma; Tvsvgk Tilak; Sameer Bakhshi; Vinod Raina; Lalit Kumar; SurendraPal Chaudhary; RanjitKumar Sahoo; Ritu Gupta; Sanjay Thulkar
Journal:  ESMO Open       Date:  2017-02-13

7.  Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren.

Authors:  Guglielmo Campus; Fabio Cocco; Giovanna Carta; Maria Grazia Cagetti; Charlotte Simark-Mattson; Laura Strohmenger; Peter Lingström
Journal:  Clin Oral Investig       Date:  2013-05-05       Impact factor: 3.573

8.  Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation.

Authors:  Benedetta Cinque; Cristina La Torre; Francesca Lombardi; Paola Palumbo; Michel Van der Rest; Maria Grazia Cifone
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.